You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 129 No. 7, July 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (28)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Oncology
 •Head & Neck Cancer
 •Genetics of Head & Neck Disease
 •Neoplasms of Head & Neck
 •Pathology of Head & Neck
 •Prognosis/ Outcomes
 •Genetics
 •Genetic Counseling/ Testing/ Therapy
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Delineating Genetic Pathways of Disease Progression in Head and Neck Squamous Cell Carcinoma

Maria J. Worsham, PhD; Gerard Pals, PhD; Jan P. Schouten, PhD; Rosalind M. L. van Spaendonk, PhD; Adriane Concus, MD; Thomas E. Carey, PhD; Michael S. Benninger, MD

Arch Otolaryngol Head Neck Surg. 2003;129:702-708.

Objective  To identify altered gene targets that characterize disease progression in squamous cell carcinoma (SCC) of the head and neck (HNSCC). Genetic alterations in HNSCC cell lines reflect the tumor in vivo and can serve as valuable tools to study the development and progression of HNSCC. Identification of key molecular events may be useful for more accurate distinction of prognostic groups for selection and targeting of therapy.

Design  Individual gene loci were analyzed for genetic alterations using a novel genomewide strategy.

Subjects  Head and neck squamous cell carcinoma primary (A) and recurrent or metastatic (B) cell lines UMSCC-11A/11B, UMSCC-17A/17B (previously karyotyped), and UMSCC-81A/81B are described.

Results  At the genome level, loss and gain of genetic loci concurred with tumor karyotypes. Several abnormal gene loci not apparent by cytogenetics were also identified. All except 11B indicated loss of CDKN2A (encodes p14 and p16), with concomitant loss of CDKN2B (encodes p15) in 11A, 17B, and 81A. All 6 cell lines showed gain of PIK3CA (encodes a PI3 kinase) located at 3q26.3.

Conclusions  We provide evidence for the role of 3 critical pathways in the development and progression of HNSCC. The CDKN2A/B genes encode various components of the Rb and p53 pathways, and the PIK3CA gene makes a catalytic subunit of the protein phosphatidylinositol 3-OH kinase (PI3K), which is known to be involved in the PI3K/ATK signaling pathways. Molecular events may ultimately serve to achieve genomic alterations that set off an interplay among key gene loci along discrete genetic pathways used by tumor cells in HNSCC.


From the Research Division (Drs Worsham and Concus), Department of Otolaryngology–Head and Neck Surgery (Drs Concus and Benninger), Henry Ford Health System, Detroit, Mich; Department of Clinical Genetics, VU Medical Center, Amsterdam, the Netherlands (Drs Pals and van Spaendonk); Microbiology Research Center–Holland, Amsterdam (Dr Schouten); and Department of Otolaryngology–Head Neck Surgery, University of Michigan, Ann Arbor (Dr Carey). The authors have no relevant financial interest in this article.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Methylation of Multiple Genes as Diagnostic and Therapeutic Markers in Primary Head and Neck Squamous Cell Carcinoma
Chen et al.
Arch Otolaryngol Head Neck Surg 2007;133:1131-1138.
ABSTRACT | FULL TEXT  

An Epigenetically Derived Monoclonal Origin for Recurrent Respiratory Papillomatosis
Stephen et al.
Arch Otolaryngol Head Neck Surg 2007;133:684-692.
ABSTRACT | FULL TEXT  

Epigenetic events of disease progression in head and neck squamous cell carcinoma.
Worsham et al.
Arch Otolaryngol Head Neck Surg 2006;132:668-677.
ABSTRACT | FULL TEXT  

Overexpression of Focal Adhesion Kinase in Head and Neck Squamous Cell Carcinoma Is Independent of fak Gene Copy Number.
Canel et al.
Clin. Cancer Res. 2006;12:3272-3279.
ABSTRACT | FULL TEXT  

Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
Worsham et al.
Arch Otolaryngol Head Neck Surg 2006;132:409-415.
ABSTRACT | FULL TEXT  

Rapid and quantitative detection of homologous and non-homologous recombination events using three oligonucleotide MLPA
Langerak et al.
Nucleic Acids Res 2005;33:e188-e188.
ABSTRACT | FULL TEXT  

Methylation-Specific MLPA (MS-MLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences
Nygren et al.
Nucleic Acids Res 2005;33:e128-e128.
ABSTRACT | FULL TEXT  

{Delta}Np63{alpha} Expression Is Regulated by the Phosphoinositide 3-Kinase Pathway
Barbieri et al.
J. Biol. Chem. 2003;278:51408-51414.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.